Yongan Futures (600927), a Portfolio Company of TTGG, Has Set a Benchmark in the Futures Industry by Getting Listed on the Shanghai Stock Exchange.

TTGG Portfolio Company Estone was Honored as the "Golden Bull Best IPO Case" by China Securities Journal

Bio-Sincerity(301096), a Portfolio Company of TTGG, was Listed on the Growth Enterprise Market (GEM), Becoming a Benchmark for China's Comprehensive "Pharmaceuticals + Clinical" Integrated CRO Enterpr

Multiple TTGG Hard Tech Portfolio Companies were Awarded the Zero2IPO 2021 Venture50 Award

TTGG Portfolio Company OriGynMed Has Invested in Zonsun Healthcare, Advancing its Strategic Business Layout in Women's Health

TTGG Participated in Wyze Biotech's Series A Round of Investment. Wyze Biotech is the Pioneer of Global Spot Universal DNT Immune Cell Therapy